Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data

@article{Sundstrm2014BloodPT,
  title={Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data},
  author={J. Sundstr{\"o}m and H. Arima and M. Woodward and R. Jackson and Kunal N. Karmali and D. Lloyd-Jones and C. Baigent and J. Emberson and K. Rahimi and S. MacMahon and Anushka Patel and V. Perkovic and F. Turnbull and B. Neal},
  journal={The Lancet},
  year={2014},
  volume={384},
  pages={591-598}
}
BACKGROUND We aimed to investigate whether the benefits of blood pressure-lowering drugs are proportional to baseline cardiovascular risk, to establish whether absolute risk could be used to inform treatment decisions for blood pressure-lowering therapy, as is recommended for lipid-lowering therapy. METHODS This meta-analysis included individual participant data from trials that randomly assigned patients to either blood pressure-lowering drugs or placebo, or to more intensive or less… Expand
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
  • Amanda Larry Ale Folkert W Nigel S Eivind Henry Frank P J Adler Agodoa Algra Asselbergs Beckett Berge Black , A. Adler, +89 authors Jiguang Wang
  • Medicine
  • The Lancet
  • 2021
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 62 REFERENCES
...
1
2
3
4
5
...